Device Trial Radar · NCT04963179
PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.
Last checked: Nov 20, 2026Latest source record: Mar 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
160
Actual
Start
Nov 29, 2021
Primary completion
Nov 11, 2023
Study completion Dec 2026
Sponsor
- Lead sponsor
- WomedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 15, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
PREG2 is a randomized controlled trial that aims to evaluate efficacy in preventing intrauterine adhesion recurrence after hysteroscopic adhesiolysis of a novel intrauterine barrier film named Womed Leaf
Conditions
- Asherman Syndrome
- Intrauterine Adhesion
Interventions
Womed LeafDevice
Womed Leaf™ device is composed of a uterine anti-adhesion film pre-loaded inside a flexible inserter. Womed Leaf™ is inserted in the uterine cavity by the gynecologist surgeon as a film folded into a 5 mm diameter flexible inserter. Once released, the film will unfold and swell into the uterine cavity to keep uterus walls separated. It is degraded and discharged naturally through the cervix and vagina.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy - IUA SeverityTime frame: At second look hysteroscopy between 4 and 8 weeks
- Safety - Adverse EventsTime frame: At second look hysteroscopy between 4 and 8 weeks
Locations
15 sites in 7 countries. Site status is shown where the registry gives one.
Gent UZ
Ghent, Belgium
Guangdong Maternal and Child Health Hospital
Guangzhou, China
Women's Hospital School Of Medicine Zhejiang University
Hangzhou, China
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.